Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.4.0.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues:    
Revenue from services $ 252,522 $ 2,069
Revenue from products 19,899 15,486
Revenue from transfer of intellectual property and other 18,616 12,529
Total revenues 291,037 30,084
Costs and expenses:    
Cost of service revenue 137,597 2,259
Cost of product revenue 9,939 8,061
Selling, general and administrative 128,001 17,446
Research and development 27,822 25,503
Contingent consideration 1,753 5,175
Amortization of intangible assets 13,443 2,665
Grant repayment 0 25,889
Total costs and expenses 318,555 86,998
Operating loss (27,518) (56,914)
Other income and (expense), net:    
Interest income 43 8
Interest expense (1,787) (2,565)
Fair value changes of derivative instruments, net (1,423) (49,788)
Other income (expense), net 546 (1,508)
Other income and (expense), net (2,621) (53,853)
Loss before income taxes and investment losses (30,139) (110,767)
Income tax benefit (provision) 20,506 (5,509)
Loss before investment losses (9,633) (116,276)
Loss from investments in investees (2,345) (1,761)
Net loss (11,978) (118,037)
Less: Net loss attributable to noncontrolling interests 0 (925)
Net loss attributable to common shareholders $ (11,978) $ (117,112)
Loss per share, basic and diluted:    
Net loss per share $ (0.02) $ (0.26)
Weighted average common shares outstanding, basic and diluted 545,823,434 446,480,884